Natalizumab therapy is associated with greater variability in JC Virus Antibody levels

被引：0
|
作者：
Peters, John [1 ]
Williamson, Eric [1 ]
机构：
[1] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P5.370
引用
收藏
页数：2
相关论文
共 50 条
  • [31] JC virus antibodies index on natalizumab treatment: fluctuations and seroconversion
    Lanzillo, R.
    Liuzzi, R.
    Amato, L.
    Vacchiano, V.
    Moccia, M.
    Vacca, G.
    Morra, V. Brescia
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 255 - 255
  • [32] Influenza-virus-vaccineIncrease in anti-JC virus antibody levels: case report
    Reactions Weekly, 2016, 1614 (1) : 100 - 100
  • [33] JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients
    Mancuso, Roberta
    Saresella, Marina
    Hernis, Ambra
    Marventano, Ivana
    Ricci, Cristian
    Agostini, Simone
    Rovaris, Marco
    Caputo, Domenico
    Clerici, Mario
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [34] JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients
    Roberta Mancuso
    Marina Saresella
    Ambra Hernis
    Ivana Marventano
    Cristian Ricci
    Simone Agostini
    Marco Rovaris
    Domenico Caputo
    Mario Clerici
    Journal of Translational Medicine, 10
  • [35] Immunological Hallmarks of JC Virus Replication in Multiple Sclerosis Patients on Long-Term Natalizumab Therapy
    Hendel-Chavez, Houria
    de Herve, Marie-Ghislaine de Goer
    Giannesini, Claire
    Mazet, Anne-Aurelie
    Papeix, Caroline
    Louapre, Celine
    Chardain, Audrey
    Boutarfa, Nassima
    Theaudin, Marie
    Adams, David
    Gasnault, Jacques
    Stankoff, Bruno
    Taoufik, Yassine
    JOURNAL OF VIROLOGY, 2013, 87 (10) : 6055 - 6059
  • [36] Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn's Disease and Effects of Natalizumab Therapy
    Bellaguarda, Emanuelle
    Keyashian, Kian
    Pekow, Joel
    Rubin, David T.
    Cohen, Russell D.
    Sakuraba, Atsushi
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (11) : 1919 - 1925
  • [37] JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level
    Lanzillo, Roberta
    Liuzzi, Raffaele
    Vallefuoco, Luca
    Moccia, Marcello
    Amato, Luca
    Vacca, Giovanni
    Vacchiano, Veria
    Portella, Giuseppe
    Morra, Vincenzo Brescia
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 807 - 814
  • [38] JC virus latency and reactivation in natalizumab-treated MS patients
    Chalkias, Spyridon
    Dang, Xin
    Bord, Evelyn
    Batson, Stephanie
    Stein, Marion
    Kinkel, Philip
    Sloane, Jacob
    Ionete, Carolina
    Koralnik, Igor J.
    JOURNAL OF NEUROVIROLOGY, 2013, 19 : S20 - S20
  • [39] Study of the JC virus presence in multiple sclerosis patients treated with natalizumab
    Dominguez-Mozo, M. I.
    Garcia-Montojo, M.
    De las Heras, V.
    Garcia-Martinez, M. A.
    Arias-Leal, A.
    Casanova, I.
    Alvarez-Lafuente, R.
    Arroyo, R.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 370 - 371
  • [40] Systematic Assessment of JC Virus in Multiple Sclerosis Patients Treated with Natalizumab
    Slesari, Iuliana
    Heinzlef, Olivier
    Poveda, Jean-Dominique
    NEUROLOGY, 2010, 74 (09) : A369 - A369
12345